Stock Groups

Thermo Fisher Scientific Earnings, Revenue Beat in Q3 -Breaking

by Mike Robinson

[ad_1]

© Reuters. Thermo Fischer Scientific Earnings and Revenue Beat in Q3

Thermo Fisher Scientific, NYSE: – Investing.com reported Wednesday the results of their third quarter. They beat forecasts by analysts and generated revenue above expectations.

Thermo Fisher Scientific reported earnings per share at $5.76 for revenue $9.33B. Investing.com polled analyst to predict EPS of 4.68 on revenues of $8.33B.

Thermo Fisher Scientific shares rose 30% in the first quarter, but are down by 1.39% from September 24’s 52-week peak of $616.93. They are outperforming the S&P 500 which is up 21.8% from the start of the year.

Thermo Fisher Scientific’s earnings are in line with other top Healthcare sectors this month

Thermo Fisher Scientific’s report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.

Abbott Labs exceeded expectations by beating all forecasts on October 20, with $1.4 third quarter earnings per share on revenues of $10.93B. This compares to $0.9449 on revenues of $9.56B.

You can keep up-to date on the latest earnings reports by visiting Investing.com’s earnings calendar

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]